Because MORT is an ETF, it does not receive its own analyst price targets the way an individual company does. Brokerage analysts instead set targets on the underlying mortgage REITs that MORT holds. A weighted aggregate of those holding-level targets, as compiled by MarketBeat, was roughly in line with the fund's price in early November 2026, providing context but not a usable standalone objective for the ETF itself.
The $9 figure is therefore a fallback target grounded in publicly discussed technical levels. MORT spent much of 2026 trading between roughly $9 and $10 before a sharp late-year decline carried it toward $7. Reclaiming the $9 area—a former support zone that broke down—is a realistic recovery milestone discussed in market commentary, and it sits about 29% above the recent price. It is a technical objective, not a forecast or a consensus.
MORT recently traded around $7.00, with some sources showing closes near $7.18 in mid-November and others near $6.96 by late November as the fund slid toward its 52-week low of $6.80. The fund's 52-week high of $11.44 reflects how far the sector has fallen. Reaching $9 would require an advance of roughly 29%—a substantial move that would mean recovering roughly half of the decline from the highs.
The path would depend primarily on the underlying mortgage REIT sector. These companies borrow short-term and invest in mortgage-backed securities and real-estate loans, so their net interest margins and book values are highly sensitive to Federal Reserve policy, yield-curve shape, and credit conditions. A stabilization in rates or a narrowing of mortgage spreads could support book values and, in turn, the ETF's price.
The $7.00 area and the 52-week low near $6.80 represent the nearest support levels; a decisive break below them would leave the fund in uncharted territory for the year. On the upside, the $9.00 target aligns with a former support zone that became resistance after the late-year breakdown, making it a meaningful technical milestone. Above that, the $10 and $11.44 levels mark progressively larger recovery targets. The fund's persistent decline through the second half of 2026 signals a clearly established downtrend that would need to be reversed before any sustained move toward $9 could take hold.
Technical recovery objectives such as $9 do not carry a defined time horizon, unlike a 12-month analyst target. Investors should instead monitor the factors most likely to move the fund over the coming quarters: Federal Reserve rate decisions, Treasury yield movements, mortgage spread trends, and quarterly earnings and book-value disclosures from Annaly, AGNC, and other top holdings. Changes in dividend declarations and any shifts in fund flows also matter, since mREIT payouts can be adjusted in response to earnings pressure. None of these observations constitutes a forecast.
AI Daily Buy/Sell Signals use artificial intelligence to continuously monitor thousands of stocks and ETFs, including MORT, and generate Buy, Sell, or Hold signals based on changing market conditions, technical behavior, and AI-driven analysis. Rather than relying on a single metric, the system aims to synthesize multiple signals so traders can discover opportunities, monitor existing positions, and spot shifting trends more efficiently. For those tracking a volatile, rate-sensitive fund like MORT, this type of automated screening can help surface turning points as they develop.
The question of whether MORT can reach $9 ultimately depends on the trajectory of interest rates and the health of the mortgage REIT sector. The $9 objective is a technical recovery milestone, not an analyst consensus, and it sits roughly 29% above recent prices near $7.00. Supporting the case are a high distribution yield, discounted book values across holdings, and the possibility of rate stability. Working against it are persistent rate pressure, credit risk, and a concentrated portfolio that has already given back much of its 2026 gains. Investors should watch Fed policy, mortgage spreads, and book-value trends before drawing any conclusions—and no outcome is guaranteed.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
A.I.dvisor indicates that over the last year, MORT has been closely correlated with REET. These tickers have moved in lockstep 76% of the time. This A.I.-generated data suggests there is a high statistical probability that if MORT jumps, then REET could also see price increases.
| Ticker / NAME | Correlation To MORT | 1D Price Change % | ||
|---|---|---|---|---|
| MORT | 100% | -1.15% | ||
| REET - MORT | 76% Closely correlated | -1.02% | ||
| ICF - MORT | 74% Closely correlated | -0.73% | ||
| IYR - MORT | 55% Loosely correlated | -0.87% | ||
| VNQ - MORT | 54% Loosely correlated | -0.97% | ||
| SCHH - MORT | 52% Loosely correlated | -0.83% | ||
More | ||||